Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation

American Journal of Surgical Pathology

Volumn 24, Issue 7, 2000, Pages 1004-1008

  Saunders, Michael D ^a   Shulman, Howard M ^a   Murakami, Carol S ^a   Chauncey, Thomas R ^a   Bensinger, William I ^a   McDonald, George B ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Autologous transplantation; Bile duct injury; Cholestasis; Graft versus host disease; Hematopoietic cell transplantation

Indexed keywords

ALKALINE PHOSPHATASE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; APOPTOSIS; ARTICLE; AUTOTRANSPLANTATION; BILE DUCT INJURY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CRYPT CELL; DRUG RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; RECIPIENT; STOMACH BIOPSY;

ACUTE DISEASE; ALKALINE PHOSPHATASE; APOPTOSIS; BILE DUCTS, INTRAHEPATIC; CHOLESTASIS; EPITHELIAL CELLS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISONE;

EID: 0033929238     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200007000-00012     Document Type: Article

References (40)

1. Barredo JC, Yusuf U, Hahn A, Abboud MR, Laver J. Progressive autologous graft-versus-host disease induced by cyclosporine A. Bone Marrow Transplant 1996;18:659-62.
2. Boeckh M, Stevens-Ayers T, Bowden RA. Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation. J Infect Dis 1996;174:907-12.
3. Carreras E, Granena A, Navasa M, et al. Transjugular liver biopsy in bone marrow transplantation. Bone Marrow Transplant 1993; 11:21-6.
4. Crawford JM. Graft-versus-host disease of the liver. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Graft-Versus-Host Disease, 2nd ed. New York, NY: Marcel Dekker Inc, 1997:315-36.
5. Crawford JM, Boyer JL. Clinicopathology conferences: inflammation-induced cholestasis. Hepatology 1998;28:253-60.
6. Dale BM, Atkinson K, Kotasek D, Biggs JC, Sage RE. Cyclosporine-induced graft-versus-host disease in two patients receiving syngeneic bone marrow transplants. Transplant Proc 1989; 21:3816-7.
7. Demirer T, Buckner CD, Appelbaum FR, et al. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation for advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels. Bone Marrow Transplant 1996;17:341-6.
8. Desmet VJ. Histopathology of cholestasis. Verhandlungen der Deutschen Gesellschaft fur Pathologie 1995;79:233-40.
9. Einsele H, Ehninger G, Schneider EM, et al. High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Transplantation 1988;45:579-85.
10. Giralt S, Weber D, Colome M, et al. Phase 1 trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue. J Clin Oncol 1997;15:667-73.
11. Hackman RC, Wolford JL, Gleaves CA, et al. Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods. Transplantation 1994;57:231-7.
12. Hess AD, Thoburn CJ. Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease. Immunol Rev 1997;157:111-23.
13. Hood AF, Vogelsang GB, Black LP, Farmer ER, Santos GW. Acute graft-versus-host disease. Development following autologous and syngeneic bone marrow transplantation. Arch Dermatol 1987;123:745-50.
14. Jones RJ, Vogelsang GB, Hess AD, et al. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989;i:754-7.
15. Kennedy MJ, Vogelsang GB, Beveridge RA, et al. Phase 1 trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1993;11:478-84.
16. Kennedy MJ, Vogelsang GB, Jones RJ, et al. Phase I trial of interferon-gamma to potentiate cyclosporine A-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1994;12:249-57.
17. List AF, Spier C, Greer J, et al. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 1993;11:1652-60.
18. Martin RW, Farmer ER, Altomonte VL, Vogelsang GB, Santos GW. Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient. Arch Dermatol 1995;131:333-5.
19. Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990;76:1464-72.
20. McDonald GB, Hinds MS, Fisher LB, et al. Venocclusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993;118:255-67.
21. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984;4:116-22.
22. Murakami CS, Louie W, Chan GS, et al. Biliary obstruction in hematopoietic cell transplant recipients: an uncommon diagnosis with specific causes. Bone Marrow Transplant 1999;23:921-7.
23. Pati AR, Godder KT, Abhyankar SH, Gee AP, Henslee-Downey PJ. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma. Bone Marrow Transplant 1996;17:1081-3.
24. Phillips MJ, Poucell S, Oda M. Biology of disease. Mechanisms of cholestasis. Lab Invest 1986;54:593-608.
25. Ponec RJ, Hackman RC, McDonald GB. Endoscopic and histologie diagnosis of intestinal graft-vs-host disease after marrow transplantation. Gastrointest Endosc 1999;49:612-21.
26. Rainey MG, Harrison P, Hows JM, et al. Spontaneous graft-versus-host disease following autologous peripheral blood progenitor cell transplantation in chronic myeloid leukemia. Bone Marrow Transplant 1996;17:1077-9.
27. Rappeport J, Mihm M, Reinharz E, Lopansri S, Parkman R. Acute graft-versus-host disease in recipients of bone marrow transplant from identical twin donors. Lancet 1979;ii:717-20.
28. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Venocclusive disease of the liver after marrow transplantation: histologic correlates of clinical signs and symptoms. Hepatology 1994;19:1171-80.
29. Shulman HM, Gooley T, Dudley MD, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995;59: 1015-22.
30. Shulman HM, Sharma P, Amos D, Fenster LF, McDonald GB. A coded histologic study of hepatic graft-versus-host disease after human marrow transplantation. Hepatology 1988;8:463-70.
31. Stockschlaeder M, Storb R, Pepe M, et al. A pilot study of low dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation. Br J Haematol 1992;80:49-54.
32. Strasser SI, McDonald GB. Hepatobiliary complications of hematopoietic stem cell transplantation. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, 8th ed. Philadelphia, PA: Lippincott-Raven, 1999:1617-41.
33. Strasser SI, McDonald GB. Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood 1999;93:1127-36.
34. Sullivan KM. Graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation, 2nd ed. Cambridge, MA: Blackwell Scientific Publications, 1999:515-36.
35. Thien SW, Goldman JM, Galton DG. Acute 'graft-versus-host disease' after autografting for chronic granulocytic leukemia in transplantation. Ann Intern Med 1981;94:210-4.
36. Tzung S-P, Hackman RC, Hockenbery DM, Bensinger W, Schiffman K, McDonald GB. Lymphocytic gastritis resembling graft-vs-host disease following autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 1998;4:43-8.
37. Weaver CH, Bensinger WI, Appelbaum FR, et al. Phase I study of high dose busulfan, melphalan, and thiotepa with autologous stem cell support in patients with refractory malignancies. Bone Marrow Transplant 1994;14:813-9.
38. Wu D, Hockenbery DM, Brentnall TA, et al. Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation 1998;66:1319-24.
39. Yasmineh WG, Filipovich AH, Killeen AA. Serum 5′nucleotidase and alkaline phosphatase - highly predictive liver function tests for the diagnosis of graft-versus-host disease in bone marrow transplant recipients. Transplantation 1989;48:809-14.
40. Yeager AM, Vogelsang GB, Jones RJ, et al. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation. Blood 1992;79:3031-5.